simpleDigital Health Ecosystem MappingMental HealthPharmaceutical

H1 2024 Digital Health Funding: Global Key Trends Report

During the first half of 2024, the Digital Health sector experienced notable trends and shifts. Despite broader venture slowdowns, digital health funding demonstrated remarkable resilience, with Q2 2024 outperforming Q1 ($7.1 billion vs. $5.3 billion). Beyond funding, two key innovation hubs have emerged over the past 12 months: TechBio and Health Systems. As the ecosystem continues to experience high-profile ventures closing down due to miscalculated business models, and investors remain in a wait-and-see holding pattern, the dust has not yet entirely settled from the funding collapse in 2022 and 2023. The period of stabilisation will likely continue throughout the rest of 2024.

H1 2024 Digital Health Global Key Trends Report_Title

Overview of Global Digital Health Funding in H1 2024

Galen Growth is pleased to share our 2024 Mid-Year Global Analysis on Digital Health innovation, focusing on the key trends in Digital Health Funding in H1 2024. This comprehensive report explores the global startup ecosystem for Digital Health, highlighting the current trends driving demand. Our analysis covers ecosystem growth, the most active partners, regulatory approvals, and venture funding.

Key Highlights from the H1 2024 Report

  • Robust Investment: The Digital Health sector saw strong performance in H1 2024, with $12.4 billion invested across 719 deals, showcasing resilience and growth despite expectations of a funding winter.
  • Venture Capital Surge: Q2 2024 marked a 34% increase in venture funding over Q1, with a notable rise in Growth Stage venture funding in North America, indicating a positive trend for investor interest in the latter half of the year.
  • Increasing Partnerships: Healthcare providers are leading the charge in digital partnerships, accounting for 21% of all collaborations, highlighting the integration of AI technology in enhancing patient care and operational efficiency. Discover how we track partnerships in Digital Health
  • AI-Driven Funding Focus: Research Solutions (TechBio) dominated Digital Health funding, receiving 20% of the total venture capital, while AI ventures represented 57% of the funding, underscoring the significant impact of AI on the industry’s growth trajectory.

Featured companies in the Global Key Trends Report

The report features a diverse range of companies driving innovation in the Digital Health sector, including: Adonis, Formation Bio, Marble Health, SmarterDx, Sensi.Ai, Grayce, Sword Health, Xaira Therapeutics, Abridge, Freenome, Talkiatry, Blackrock Neurotech, Foodsmart, Koios Medical, PharmEasy, Sharecare, LumiraDx, Invitae, Cloudbreak Health, ScienceIO, Nuvo, VSee Lab, OmnigenicsAI, Tempus AI, XtalPi (晶泰科技), Alto Neuroscience, Metagenomi, MaNaDr, Mika, Iktos, Asleep (에이슬립), ConcertAI, Ultrasight, AstraZeneca, Daiichi Sankyo, Italfarmaco, Samsung Life Insurance, NVIDIA, Mayo Clinic

About HealthTech Alpha

Powered by HealthTech Alpha, Galen Growth's proprietary solution and the world's leading platform for Digital Health private market data, intelligence, and insights, this report provides unmatched, non-biased, and data-driven coverage of the global Digital Health ecosystems. Learn more about HealthTech Alpha.Download the full H1 2024 Digital Health: Global Key Trends Report Explore our other Digital Health reports and insights

Explore our latest Digital Health reports

Is Big Tech Important to Digital Health Innovation? Pharma Innovation Powered by AI UK Digital Health Investment Insights 2024